IMCB Seminar: Meaningful Innovation: Pfizer Collaboration Strategy in the Emerging Sciences

You are invited to attend this seminar hosted by the Institute of Molecular and Cell Biology:

Date: Monday, 29 May 2023
Time: 3.00PM – 4.00PM
Venue: IMCB Seminar Room 03-46, Level 3 Proteos, Biopolis, Singapore 138673 (Physical)

Speaker: Dr Anand Gautam
Host: Dr Sharrada Subramaniam, IMCB

Meaningful Innovation: Pfizer Collaboration Strategy in the Emerging Sciences

Biography
Dr Anand Gautam has had wide-ranging leadership roles in R&D and innovation strategies in Inflammation/Autoimmune Diseases/Cancer at international biotech and pharmaceutical companies for over 30 years. Anand has spent over 12 years as an academic in Immunology in prestigious research centres in the UK (PhD at University of London), US (post-doc at Stanford University, California), and Australia (Academic positions at ANU, Canberra & UQ, Brisbane). Before joining Pfizer as a Head of External Science & Innovation, ANZ & Southeast Asia in April 2017, Anand was a Senior Director of R&D Innovation Sourcing at Novo Nordisk, Copenhagen for eight years. Prior to that, Anand was VP of R&D at Progen (Brisbane, Australia), and SVP of External Science & Collaboration at Pharmexa (Denmark).

Dr Gautam has obtained numerous grants to carry out his scientific research, including an NIH grant; a Career Development Award from Juvenile Diabetes Foundation International, USA; and a Howard Florey Young Investigator’s Award from the ANU, Canberra. Anand serves on number committees (e.g. AusBiotech and Bridge Program at MTPconnect, Australia), is a Life Science Queensland Ambassador, and is an Adjunct Professor at The Institute for Molecular Biosciences, University of Queensland.
　
　
ALL ARE WELCOME　(No registration required)
For upcoming seminars in IMCB, please visit https://www.a-star.edu.sg/imcb